Cargando…

Delayed cutaneous hypersensitivities to COVID-19 vaccination: Phenotypic distribution and tolerability of vaccine rechallenge

Detalles Bibliográficos
Autores principales:	De Luca, Joseph F., Awad, Andrew, Vogrin, Sara, Waldron, Jamie L., McInnes, Kerryn, Gibney, Grace, Hall, Rebecca, Douglas, Abby P., Chua, Kyra Y.L., Holmes, Natasha E., Trubiano, Jason A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2023
Materias:	Clinical Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174467/ https://www.ncbi.nlm.nih.gov/pubmed/37178767 http://dx.doi.org/10.1016/j.jaip.2023.04.045

Ejemplares similares

Phenotypic distribution and tolerability of re-vaccination in individuals with delayed hypersensitivity to COVID-19 vaccines
por: De Luca, Joseph, et al.
Publicado: (2023)

Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection
por: Chua, Kyra Y.L., et al.
Publicado: (2020)

Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis
por: Awad, Andrew, et al.
Publicado: (2021)

1787. The Safety and Efficacy of an Oral Penicillin Rechallenge Program in Cancer Patients: A Pilot Multicenter Study
por: Smibert, Olivia, et al.
Publicado: (2018)

1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
por: Smibert, Olivia, et al.
Publicado: (2018)

Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol
por: Copaescu, Ana-Maria, et al.
Publicado: (2022)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Development and Validation of a Sulfa Antibiotic Allergy Clinical Decision Rule
por: Waldron, Jamie L., et al.
Publicado: (2023)

Staff to staff transmission as a driver of healthcare worker infections with COVID-19
por: Gordon, Claire L., et al.
Publicado: (2021)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)

Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot randomised controlled trial
por: Rose, Morgan, et al.
Publicado: (2023)

The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study
por: Trubiano, Jason A, et al.
Publicado: (2018)

SEVERE ACTIVE CUTANEOUS HYPERSENSITIVITY IN THE RAT PRODUCED BY HEMOPHILUS PERTUSSIS VACCINE
por: Rowley, Donald A., et al.
Publicado: (1959)

Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccine
por: Wong, Christine Y., et al.
Publicado: (2021)

COVID-Care – a safe and successful digital self-assessment tool for outpatients with proven and suspected coronavirus-2019
por: Drewett, George P, et al.
Publicado: (2021)

Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination—a narrative review
por: Wollina, Uwe, et al.
Publicado: (2021)

Melanoma: BRAFi Rechallenge
por: Kosmidis, Christoforos S., et al.
Publicado: (2023)

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
por: Copaescu, Ana, et al.
Publicado: (2021)

Cutaneous Metal Hypersensitivity Reaction
por: Yang, Sun, et al.
Publicado: (2022)

Current Status in Rechallenge of Immunotherapy
por: Hu, Han, et al.
Publicado: (2023)

Drugs and Vaccines Hypersensitivity in Children with Mastocytosis
por: Mori, Francesca, et al.
Publicado: (2022)

Validation Study of a Clinical Predictive Model for Fluconazole Resistance in Patients With Candida Bloodstream Infection
por: Collis, Brennan, et al.
Publicado: (2023)

Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Genetic control of cutaneous basophil hypersensitivity
Publicado: (1976)

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
por: Copaescu, Ana, et al.
Publicado: (2021)

Delayed Cutaneous Hypersensitivity Reactions in Patients With Kaposi's Sarcoma
por: Taylor, J. F., et al.
Publicado: (1974)

Rechallenge of lamotrigine after development of rash
por: Houser, Jennifer, et al.
Publicado: (2018)

Lithium rechallenge after renal transplant
por: Beasley, Anna K., et al.
Publicado: (2018)

5-Fluorouracil Rechallenge After Cardiotoxicity
por: Desai, Aakash, et al.
Publicado: (2020)

COVID-MATCH65—A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2
por: Trubiano, Jason A., et al.
Publicado: (2020)

Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
por: Sprute, Rosanne, et al.
Publicado: (2021)

Delayed-type hypersensitivity skin reaction to Covid-19 vaccine
por: Robb, Mia L., et al.
Publicado: (2021)

Dysphonia after Bevacizumab Rechallenge: A Case Report
por: Carter, Corey A., et al.
Publicado: (2015)

Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis()
por: Murarasu, Anne, et al.
Publicado: (2023)

Rare Hypersensitivity Myocardial Reactions Following COVID-19 Vaccination: Hypersensitivity Myocardial Infarction (Kounis Syndrome) and Hypersensitivity Myocarditis
por: Kounis, Nicholas G., et al.
Publicado: (2022)

mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase
por: Koo, Grace, et al.
Publicado: (2022)

CUTANEOUS HYPERSENSITIVITY REACTIONS TO CELLULAR ISOANTIGENS IN RATS
por: Streilein, J. W., et al.
Publicado: (1967)

CUTANEOUS DRUG HYPERSENSITIVITY: IMMUNOLOGICAL AND GENETIC PERSPECTIVE
por: Ghosh, Kisalay, et al.
Publicado: (2011)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
por: Chopra, Shara, et al.
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech/ibuprofen/paracetamol/meloxicam: Generalised cutaneous hypersensitivity reaction with acute hepatitis: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7bb8rda1vdqoo6avsppk4k87tg